Opko Health (OPK) Invested Capital (2010 - 2026)

Opko Health has reported Invested Capital for 17 years, with the latest figure at $1.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 8.28% year-over-year to $1.2 billion; the trailing twelve-month figure through Mar 2026 stood at $1.2 billion (down 8.28% YoY), and the FY2025 full-year result was $1.3 billion, down 7.4% from the prior year.
• Invested Capital for Q1 2026 stood at $1.2 billion, down from $1.3 billion in the prior quarter.
• The five-year high for Invested Capital was $1.7 billion in Q2 2022, with the low at $1.2 billion in Q1 2026.
• Historically, Invested Capital has averaged $1.4 billion across 5 years, with a median of $1.4 billion in 2024.
• Annual changes were most pronounced in 2024 — Invested Capital retreated 19.07% — and 2025, when it advanced 3.78%.
• Opko Health's Invested Capital stood at $1.6 billion in 2022, then declined by 9.3% to $1.4 billion in 2023, then slipped by 2.56% to $1.4 billion in 2024, then dropped by 7.4% to $1.3 billion in 2025, then declined by 5.0% to $1.2 billion in 2026.
• The last three Invested Capital figures came in at $1.2 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.